The lncRNA ITGB2-AS1, through its interaction with FOS-like 2(FOSL2), enhances nicotinamide phosphoribosyl transferase (NAMPT) expression, thereby further suppressing p53-mediated ferroptosis, and consequently fostering cisplatin resistance in NSCLC [75]. Here, NAMPT is linked to non-small cell lung carcinoma.